Bacil Pharma [BACPHAR] vs Sun Pharmaceutical [SUNPHARMA] Detailed Stock Comparison
Bacil Pharma
BSE
Loading...
Sun Pharmaceutical
NSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Bacil Pharma wins in 7 metrics, Sun Pharmaceutical wins in 10 metrics, with 0 ties. Sun Pharmaceutical appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Bacil Pharma | Sun Pharmaceutical | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 30.00 | 36.92 | Bacil Pharma |
| Price-to-Book Ratio | 1.13 | 5.32 | Bacil Pharma |
| Debt-to-Equity Ratio | 0.64 | 3.26 | Bacil Pharma |
| PEG Ratio | -0.03 | -1.89 | Sun Pharmaceutical |
| EV/EBITDA | -153.41 | 23.50 | Bacil Pharma |
| Profit Margin (TTM) | 111.61% | 19.29% | Bacil Pharma |
| Operating Margin (TTM) | -10.86% | 24.34% | Sun Pharmaceutical |
| EBITDA Margin (TTM) | N/A | 24.34% | N/A |
| Return on Equity | 1.59% | 15.08% | Sun Pharmaceutical |
| Return on Assets (TTM) | 1.58% | 11.87% | Sun Pharmaceutical |
| Free Cash Flow (TTM) | $4.01M | $119.44B | Sun Pharmaceutical |
| Dividend Yield | N/A | 1.26% | N/A |
| 1-Year Return | 92.79% | -12.47% | Bacil Pharma |
| Price-to-Sales Ratio (TTM) | 21.92 | 7.14 | Sun Pharmaceutical |
| Enterprise Value | $487.13M | $3,604.73B | Sun Pharmaceutical |
| EV/Revenue Ratio | 49.12 | 6.70 | Sun Pharmaceutical |
| Gross Profit Margin (TTM) | N/A | 79.58% | N/A |
| Revenue per Share (TTM) | $1 | $224 | Sun Pharmaceutical |
| Earnings per Share (Diluted) | $1.23 | $43.37 | Sun Pharmaceutical |
| Beta (Stock Volatility) | 0.30 | 0.31 | Bacil Pharma |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Bacil Pharma vs Sun Pharmaceutical Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Bacil Pharma | -1.60% | -1.60% | -1.81% | -11.19% | -11.53% | -30.72% |
| Sun Pharmaceutical | 0.55% | -2.88% | -6.78% | -6.19% | 0.08% | -15.63% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Bacil Pharma | 92.79% | 766.20% | 1,146.62% | 476.56% | 638.00% | 246.48% |
| Sun Pharmaceutical | -12.47% | 83.37% | 211.15% | 85.90% | 824.29% | 2,607.59% |
Performance & Financial Health Analysis: Bacil Pharma vs Sun Pharmaceutical
| Metric | BACPHAR | SUNPHARMA |
|---|---|---|
| Market Information | ||
| Market Cap | ₹217.34M | ₹3.84T |
| Market Cap Category | Small cap | Large cap |
| 10 Day Avg. Volume | 29,436 | 2,253,188 |
| 90 Day Avg. Volume | 31,562 | 2,261,516 |
| Last Close | ₹36.90 | ₹1,594.50 |
| 52 Week Range | ₹16.24 - ₹62.56 | ₹1,553.05 - ₹1,960.35 |
| % from 52W High | -41.02% | -18.66% |
| All-Time High | ₹62.56 (Dec 16, 2024) | ₹1,960.35 (Sep 30, 2024) |
| % from All-Time High | -41.02% | -18.66% |
| Growth Metrics | ||
| Quarterly Revenue Growth | N/A | 0.10% |
| Quarterly Earnings Growth | N/A | -0.20% |
| Financial Health | ||
| Profit Margin (TTM) | 1.12% | 0.19% |
| Operating Margin (TTM) | -0.11% | 0.24% |
| Return on Equity (TTM) | 0.02% | 0.15% |
| Debt to Equity (MRQ) | 0.64 | 3.26 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | ₹32.60 | ₹300.99 |
| Cash per Share (MRQ) | ₹2.05 | ₹108.88 |
| Operating Cash Flow (TTM) | ₹4.03M | ₹110.84B |
| Levered Free Cash Flow (TTM) | ₹4.04M | ₹109.29B |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | 1.26% |
| Last 12-Month Dividend | N/A | ₹21.00 |
Valuation & Enterprise Metrics Analysis: Bacil Pharma vs Sun Pharmaceutical
| Metric | BACPHAR | SUNPHARMA |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 30.00 | 36.92 |
| Forward P/E | N/A | 49.00 |
| PEG Ratio | -0.03 | -1.89 |
| Price to Sales (TTM) | 21.92 | 7.14 |
| Price to Book (MRQ) | 1.13 | 5.32 |
| Market Capitalization | ||
| Market Capitalization | ₹217.34M | ₹3.84T |
| Enterprise Value | ₹487.13M | ₹3.60T |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 49.12 | 6.70 |
| Enterprise to EBITDA | -153.41 | 23.50 |
| Risk & Other Metrics | ||
| Beta | 0.30 | 0.31 |
| Book Value per Share (MRQ) | ₹32.60 | ₹300.99 |
Financial Statements Comparison: Bacil Pharma vs Sun Pharmaceutical
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | BACPHAR | SUNPHARMA |
|---|---|---|
| Revenue/Sales | ₹0 | ₹137.86B |
| Cost of Goods Sold | N/A | ₹28.15B |
| Gross Profit | N/A | ₹109.71B |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | ₹-1.09M | ₹33.72B |
| EBITDA | ₹-1.09M | ₹47.66B |
| Pre-Tax Income | ₹8.94M | ₹31.73B |
| Income Tax | ₹2.25M | ₹8.70B |
| Net Income (Profit) | ₹6.69M | ₹22.93B |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | BACPHAR | SUNPHARMA |
|---|---|---|
| Cash & Equivalents | ₹28.57M | ₹102.69B |
| Total Current Assets | ₹29.08M | ₹526.24B |
| Total Current Liabilities | ₹1.69M | ₹181.94B |
| Long-Term Debt | N/A | ₹3.58B |
| Total Shareholders Equity | ₹254.31M | ₹724.86B |
| Retained Earnings | N/A | ₹578.62B |
| Property, Plant & Equipment | N/A | ₹100.36B |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | BACPHAR | SUNPHARMA |
|---|---|---|
| Operating Cash Flow | N/A | N/A |
| Capital Expenditures | N/A | N/A |
| Free Cash Flow | N/A | N/A |
| Debt Repayment | N/A | N/A |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | BACPHAR | SUNPHARMA |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Average Daily Volume (10 Day) | 29,436 | 2,253,188 |
| Average Daily Volume (90 Day) | 31,562 | 2,261,516 |
| Shares Outstanding | 5.89M | 2.40B |
| Float Shares | 12.10M | 1.04B |
| % Held by Insiders | 0.15% | 0.56% |
| % Held by Institutions | 0.00% | 0.25% |
Dividend Analysis & Yield Comparison: Bacil Pharma vs Sun Pharmaceutical
| Metric | BACPHAR | SUNPHARMA |
|---|---|---|
| Last 12-Month Dividend | N/A | ₹21.00 |
| Last 12-Month Dividend Yield | N/A | 1.26% |
| 3-Year Avg Annual Dividend | N/A | ₹14.67 |
| 3-Year Avg Dividend Yield | N/A | 0.46% |
| 3-Year Total Dividends | N/A | ₹44.00 |
| Ex-Dividend Date | N/A | Jul 07, 2025 |